• European Centre for Disease Prevention and Control (ECDC) intensifies the identification and tracking of mutations of the SARSCoV-2 genome across Europe with support of Eurofins Genomics

    Friday February 26th 2021

  • From SIMPLER cohorts, Eurofins Genomics successfully extracted 38.000 samples and run 40.500 samples on GWAS microarray during a one-year period.

    Monday February 15th 2021

  • Bone Therapeutics and Rigenerand sign partnership for cell therapy process development

    Thursday January 14th 2021

  • argenx and Zai Lab announce strategic collaboration for Efgartigimod in Greater China

    Thursday January 7th 2021

  • Richter and Mithra strengthen their partnership and signed a license and supply agreement for the commercialization of Estelle® to Latin America

    Wednesday December 23rd 2020

  • Eurofins Genomics joins flanders.bio

    Monday December 21st 2020

  • ONA Therapeutics, Absolute Antibody and RIC partner to create new type of biologic

    Friday December 18th 2020

  • eTheRNA and China Grand Pharma enter a strategic collaboration in the Greater China Region focussed on eTheRNA’s proprietary mRNA development products and manufacturing capabilities

    Wednesday December 2nd 2020

  • Your news here?

  • AbolerIS Pharma signed with Ouest Valorisation an exclusive world-wide license to develop new first-in-class anti-CD45RC monoclonal antibodies

    Wednesday December 2nd 2020

  • atbtherapeutics initiates agreement with iBio CDMO to manufacture game-changer atbodies to better treat cancer

    Tuesday December 1st 2020

  • Biocair and Roylance Pharma partner to provide end-to-end logistics services

    Tuesday November 10th 2020

Strategic Partners